InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Rizvi Syed Ali-aamir, Directeur Médical. Officer active across 3 companies, notably Caribou Biosciences, Inc.. Cumulatively, 6 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €33k. Activity tracked since 25 January 2022. The latest transaction was filed on 11 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Rizvi Syed Ali-aamir is Chief Medical Officer. The record shows 6 filings in total, and across the 6 sampled recent filings between 2022-01-25 and 2026-02-13, sell volume is EUR 32883 and is mainly associated with Caribou Biosciences, Inc.